Stay updated on Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.

Latest updates to the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedResults for NCT05227703 have been posted (Results First Posted estimated 2025-10-28), including primary and secondary outcomes and safety data. Related documents such as the Study Protocol and Statistical Analysis Plan were added, replacing the previous 'Results Submitted' status.SummaryDifference5%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedUpgrade notice added about funding and operations; version updated to v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check45 days agoChange DetectedVersion bumped to v3.1.0 with removal of several Drug Safety and genetics topics (e.g., Schizophrenia, Counterfeit Drugs) and the former revision note v3.0.2.SummaryDifference0.5%

- Check59 days agoChange DetectedResults are now posted (replacing 'No Results Posted'), and the revision was updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed as a minor UI change.SummaryDifference0.3%

- Check66 days agoChange DetectedThe web page has been updated to include information on Schizophrenia under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.3%

- Check73 days agoChange DetectedThe web page has added significant information regarding drug safety, counterfeit drugs, and pharmaceutical preparations, while removing several location-related details and specific medical resources.SummaryDifference2%

Stay in the know with updates to Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.